Krystal Biotech (KRYS) PT Raised to $327 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst Andrea Tan raised the price target on Krystal Biotech (NASDAQ: KRYS) to $327.00 while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
